| Patent | Date |
|---|
Pd-1 Agonist And Method Of Using Same
App 20220235132 - KEHRY; Marilyn ; et al. | 2022-07-28 |
Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3)
Grant 11,352,427 - Kehry , et al. June 7, 2 | 2022-06-07 |
Antibodies Directed Against T Cell Immunoglobulin And Mucin Protein 3 (tim-3)
App 20220169734 - King; David J. ; et al. | 2022-06-02 |
FcRn antibodies and methods of use thereof
Grant 11,345,751 - Ling , et al. May 31, 2 | 2022-05-31 |
Antibody Agents Directed Against Lymphocyte Activation Gene-3 (lag-3) And Uses Thereof
App 20220135670 - Jun; Helen Toni ; et al. | 2022-05-05 |
Antibodies Directed Against Programmed Death-1 (PD-1)
App 20220089739 - King; David J. ; et al. | 2022-03-24 |
Antibodies directed against programmed death-1 (PD-1)
Grant 11,155,624 - King , et al. October 26, 2 | 2021-10-26 |
FcRn Antibodies and Methods of Use Thereof
App 20210238275 - Ling; Leona E. ; et al. | 2021-08-05 |
Antibodies Directed Against Programmed Death-1(PD-1)
App 20210163589 - King; David J. ; et al. | 2021-06-03 |
Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)
App 20210095026 - Jun; Helen Toni ; et al. | 2021-04-01 |
Antibodies directed against lymphocyte activation gene 3 (LAG-3)
Grant 10,836,824 - Jun , et al. November 17, 2 | 2020-11-17 |
FcRn Antibodies and Methods of Use Thereof
App 20200299382 - Kehry; Marilyn ; et al. | 2020-09-24 |
Pd-1 Binding Proteins And Methods Of Use Thereof
App 20200255525 - Kind Code | 2020-08-13 |
Antibodies directed against programmed death-1 (PD-1)
Grant 10,738,117 - King , et al. A | 2020-08-11 |
FcRn antibodies and methods of use thereof
Grant 10,676,526 - Kehry , et al. | 2020-06-09 |
Antibodies Directed Against T Cell Immunoglobulin And Mucin Protein 3 (tim-3)
App 20200148770 - KEHRY; Marilyn ; et al. | 2020-05-14 |
Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)
Grant 10,508,149 - Kehry , et al. Dec | 2019-12-17 |
PD-1 binding proteins and methods of use thereof
Grant 10,428,145 - Bennett , et al. October 1, 2 | 2019-10-01 |
Antibodies Directed Against T Cell Immunoglobulin And Mucin Protein 3 (tim-3)
App 20190284280 - King; David J. ; et al. | 2019-09-19 |
Antibodies Directed Against Lymphocyte Activation Gene 3 (lag-3)
App 20190256596 - JUN; Helen Toni ; et al. | 2019-08-22 |
Antibodies Directed Against Programmed Death- 1 (pd-1)
App 20190256600 - King; David J. ; et al. | 2019-08-22 |
Antibodies Directed Against Lymphocyte Activation Gene 3 (lag-3)
App 20180127496 - JUN; Helen Toni ; et al. | 2018-05-10 |
Antibodies Directed Against T Cell Immunoglobulin And Mucin Protein 3 (tim-3)
App 20180127500 - KEHRY; Marilyn ; et al. | 2018-05-10 |
Antibodies Directed Against Programmed Death-1 (pd-1)
App 20180051082 - King; David J. ; et al. | 2018-02-22 |
Fcrn Antibodies And Methods Of Use Thereof
App 20180016334 - KEHRY; Marilyn ; et al. | 2018-01-18 |
Antibodies directed against programmed death-1 (PD-1)
Grant 9,815,897 - King , et al. November 14, 2 | 2017-11-14 |
Pd-1 Binding Proteins And Methods Of Use Thereof
App 20170088618 - Bennett; Brydon ; et al. | 2017-03-30 |
Antibodies Directed Against Programmed Death-1 (pd-1)
App 20160075783 - King; David J. ; et al. | 2016-03-17 |
Methods for proliferating and differentiating B cells with high density membrane CD40 ligand
Grant 5,817,516 - Kehry , et al. October 6, 1 | 1998-10-06 |
| 